checkAd

    EQS-News  121  0 Kommentare SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production - Seite 3


    The issuer is solely responsible for the content of this announcement.

    The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com
    Language: English
    Company: SynBiotic SE
    Münsterstr. 336
    40470 Dusseldorf
    Germany
    E-mail: office@synbiotic.com
    Internet: https://www.synbiotic.com/
    ISIN: DE000A3E5A59
    WKN: A3E5A5
    Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Tradegate Exchange
    EQS News ID: 1887037

     
    End of News EQS News Service

    1887037  23.04.2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1887037&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 
    Seite 3 von 3



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-News SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production - Seite 3 EQS-News: SynBiotic SE / Key word(s): Takeover SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production 23.04.2024 / 10:33 CET/CEST The issuer is solely responsible for the content of …

    Artikel zu den Werten

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer